Concord Biotech Limited (CONCORDBIO.BO)
INR 2153.4
(-1.05%)
INR 2153.4
(-1.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -372.86 Million INR | -232.94% |
| 2022 | 280.48 Million INR | -54.63% |
| 2021 | 618.26 Million INR | -26.52% |
| 2020 | 841.39 Million INR | 69.48% |
| 2019 | 496.46 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | 100.0% |
| 2023 Q1 | 1.71 Billion INR | 509.7% |
| 2023 Q4 | -372.86 Million INR | -116.57% |
| 2023 Q2 | 168.88 Million INR | -90.12% |
| 2023 FY | -372.86 Million INR | -232.94% |
| 2023 Q3 | 2.25 Billion INR | 1232.65% |
| 2022 Q1 | 1.61 Billion INR | 0.0% |
| 2022 FY | 280.48 Million INR | -54.63% |
| 2022 Q4 | 280.48 Million INR | 0.0% |
| 2021 FY | 618.26 Million INR | -26.52% |
| 2020 FY | 841.39 Million INR | 69.48% |
| 2019 FY | 496.46 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 127.522% |
| Biocon Limited | 140.18 Billion INR | 100.266% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 55.126% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 101.963% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | 133.761% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | -613836.181% |
| Lyka Labs Limited | 527.01 Million INR | 170.751% |
| Panacea Biotec Limited | -1.18 Billion INR | 68.532% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | 1795.681% |
| Servoteach Industries Limited | 5016.00 INR | 7433672.568% |
| SMS Lifesciences India Limited | 992.31 Million INR | 137.576% |
| Supriya Lifescience Limited | -694.68 Million INR | 46.325% |
| Syngene International Limited | -83 Million INR | -349.239% |
| TAKE Solutions Limited | 361.37 Million INR | 203.182% |
| Titan Biotech Limited | 54.62 Million INR | 782.558% |
| Transgene Biotek Limited | 139.93 Million INR | 366.462% |
| Vanta Bioscience Limited | 607.93 Million INR | 161.334% |